Building a safer CAR-T therapy
(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study has devised a new type of chimeric antigen-receptor (CAR) T cell -- a family of promising immunotherapies for cancer -- that can be switched on and off on demand.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Cancer | Cancer & Oncology | Immunotherapy | International Medicine & Public Health | Study